GHTM

Global Health and Tropical Medicine

  • GHTM
    • Vision
    • Mission
    • Governance
    • Scientific Advisory Board
  • News
    • Outreach
    • Events
      • GHTM sessions
      • Workshops
    • Articles
    • Jobs
  • Research
    • Cross-cutting issues
      • Global Pathogen Dispersion and Population Mobility
      • Drug Discovery and Drug Resistance
      • Diagnostics
      • Public Health Information
      • Fair Research Partnerships
    • Research Groups
      • PPS – Population health, policies and services
      • THOP – TB, HIV and opportunistic diseases and pathogens
      • VBD – Vector borne diseases and pathogens
      • IHC – Individual health care
    • Research in numbers
      • 2017
      • 2018
    • Projects
      • Ongoing Projects
    • Members
      • Population health, policies and services
        • PPS PhD members
        • PPS non PhD members
      • TB, HIV and opportunistic diseases and pathogens
        • THOP PhD members
        • THOP non PhD members
      • Vector-borne diseases and pathogens
        • VBD PhD members
        • VBD non PhD members
      • Individual Health Care
        • IHC PhD members
        • IHC non PhD members
      • Technical / administrative support
  • Publications
  • Education
    • Master Theses
    • PhD Defenses
  • Services
Home / Events / GHTM Sessions | Novel Strategies for Malaria Vaccine and Drug Designs

GHTM Sessions | Novel Strategies for Malaria Vaccine and Drug Designs

GHTM sessions

  • From: 12/02/2020
  • To: 12/02/2020
  • Location: Sala Professor Fraga de Azevedo | 11h00

Shigeto Yoshida  | Laboratory of Vaccinology and Applied Immunology, Kanazawa University School of Pharmacy

Shigeto Yoshida joined Kanazawa University School of Pharmacy as a professor in 2010. He received his two PhDs in Avian Virology and Immunology from Hokkaido University and in Malariology from Jichi Medical University, Japan. Bridging the fields of microbiology and immunology, he works to develop a new vaccine platform for infectious diseases. His research is now focused on malaria vaccine development. Recently, he has developed various viral vectored and recombinant protein based vaccine platforms capable of inducing long-lasting effective humoral and cellular ‘hybrid’ immune responses against malaria parasites in a murine model. He is also interested in parasite-mosquito interaction. His group has established both parasite- and mosquito-transgenesis systems to express foreign genes. He clearly aims to develop a new malaria vaccine for clinical setting. And his vaccine platform will be applicable not only for malaria but also other serious infectious diseases, such as Ebola, tuberculosis and HIV.

Events

About GHTM

GHTM is a R&D Center that brings together researchers from IHMT with a track record in Tropical Medicine and International/Global Health. It aims at strengthening Portugal's role as a leading partner in the development and implementation of a global health research agenda. Our evidence-based interventions contribute to the promotion of equity in health and to improve the health of populations.

Contacts

Rua da Junqueira, 100
1349-008 Lisboa
Portugal
+351 213 652 600
+351 213 632 105

  • Facebook
  • YouTube

Subscribe Newsletter

  • How to get to GHTM/IHMT
  • GHTM sessions
  • Research Groups
  • Cross-cutting issues
© Copyright 2020 IHMT-UNL All Rights Reserved.
  • Universidade Nova de Lisboa
  • Fundação para a Ciência e a Tecnologia

    Project UID/Multi/04413/2013

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok